The Dipyridamole Tablets, cataloged under National Stock Number 6505-01-155-0513, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Consolidated Midland Corp. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-155-0513 |
| Primary Part Number | NDC00223-0839-02 |
| Item Name | Dipyridamole Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Consolidated Midland Corp |
| Status | ACTIVE |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 75.000 MILLIGRAMS DIPYRIDAMOLE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00223-0839-02 PRIMARY | Consolidated Midland Corp (USA) |
| NDC00879-0467-10 PRIMARY | Halsey Drug Co Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00182-1354-10GENERIX DRUG CO | 3/2 Design control — primary reference U.S. Government activity |
| 1275060 | 5/9 Secondary reference Major Crown Inc |
| NDC00090-4108-48 | 5/9 Secondary reference Major Crown Inc |
| NDC00781-1478-10 | 5/9 Secondary reference Geneva Pharmaceuticals Inc |
NSN 6505-01-155-0513 is a Dipyridamole Tablets, manufactured by Consolidated Midland Corp, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-155-0513 has 2 manufacturer part numbers on file: NDC00223-0839-02 (Consolidated Midland Corp), NDC00879-0467-10 (Halsey Drug Co Inc).
Key specifications for NDC00223-0839-02: Primary Container Content Quantity: 1000.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: COATING FEATURE:SUGAR;. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.